Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma.

Clinical trial NCT05451862 · TERMINATED

Trial details

NCT number: NCT05451862
Sponsor: Terumo Europe N.V.
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-08-21
Primary completion: 2025-05-27
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.